Form 4 for FATE FATE THERAPEUTICS INC
Accepted 2022-07-08 00:00:00 ET · period of report 2022-07-07 · accession 0001209191-22-041670 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-07-08 | 2022-07-07 | FATE | Valamehr Bahram | Chief R, D Off | S - Sale+OE | $30.23 | -17.2K | 179.8K | -9% | -$518.7K |
| D | 2022-07-08 | 2022-07-07 | FATE | Valamehr Bahram | Chief R, D Off | M - OptEx | $2.73 | +17.2K | 197.0K | +10% | +$46.8K |
| D | 2022-07-08 | 2022-07-07 | FATE | Valamehr Bahram | Chief R, D Off | M - OptEx | $2.73 | -17.2K | 13.2K | -57% | -$46.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-07 | S | D | 17,158 | $30.23 | 179,834 | D | — | — | (F2) Represents the weighted average sale price of the shares sold ranging from $30.00 to $30.53 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range set forth in footnote 2. |
| 2 | Common | Common Stock | 2022-07-07 | M | A | 17,158 | $2.73 | 196,992 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-07-07 | M | D | 17,158 | $2.73 | 13,156 | D | $2.73 · — to 2027-01-04 | 17,158 Common Stock | (F3) This option is fully vested. |